AASANDHA SCHEME
Master Medicine and Consumable list as at 14th May 2026
test
| Code | mfda_code | Generic | Product name | Strength | Volume | Preparation | Master Price (MVR) |
|---|---|---|---|---|---|---|---|
| TM0121 | P1326 | Ethosuximide | Ethosuximide | 250 mg | Capsule | 3.06 | |
| TM0122 | P1716 | Ethyl Chloride | Ethyl Chloride Spray | 88 g per 100 ml | Aerosol | 253.78 | |
| M1116 | P0583 | Etofylline + Theophylline | Deriphyllin | 46.5 mg + 14 mg per 5 ml | Oral Liquid | 15.3 | |
| M1117 | P0584 | Etofylline + Theophylline | Deriphyllin | 77 + 23 mg | Tablet | 0.26 | |
| M1118 | P0585 | Etofylline + Theophylline | Deriphyllin Retard | 231 mg + 69 mg | Tablet | 1.02 | |
| M1119 | P0586 | Etofylline + Theophylline | Deriphyllin Retard | 115 + 35 mg | Tablet | 0.51 | |
| M1120 | P0587 | Etofylline + Theophylline | Etofylline + Theophylline | 84.7mg + 25.3g per ml | Injection | 3.06 | |
| M3502 | P4300 | Etoricoxib | Etohope 60 | 60 mg | Film coated Tablet | 11.62 | |
| M3505 | P4468 | Etoricoxib | Etohope 120 | 120 mg | Film coated tablet | 22 | |
| M3625 | P4315 | Etoricoxib | Etohope 90 | 90 mg | Tablet | 15.21 | |
| M1126 | P2330 | Everolimus | Certican | 0.25 mg | Tablet | 26.21 | |
| TM0711 | P4260 | Everolimus | Everolimus | 5 mg | Tablet | 532.3 | |
| M3097 | P1218 | Eye Combination | Vital Eyes | Ophthalmic Solution | 76.5 | ||
| M3496 | P3998 | Ezetimibe | Ezemibe | 10 mg | Tablet | 3.22 | |
| M1127 | P1611 | Famotidine | Topcid | 20 mg | Tablet | 1.02 | |
| M1128 | P1612 | Famotidine | Topcid | 40 mg | Tablet | 1.02 | |
| M1129 | P2277 | Famotidine | Optifam | 40 mg | Tablet | 5.1 | |
| M1130 | P2278 | Famotidine | Optifam | 20 mg | Tablet | 5.1 | |
| M3098 | P3613 | Febuxostat | Xanurix | 40 mg | Tablet | 3.06 | |
| M3099 | P3615 | Febuxostat | Xanurix | 80 mg | Tablet | 5.1 |